DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
A drug-free, physician-formulated supplement targeting hair thinning via DHT-support botanicals, marine collagen, and adaptogens.
A reasonable drug-free option, not a finasteride replacement
Nutrafol Men is among the most-studied hair-wellness supplements, and its peer-reviewed RCT did show statistically significant improvements in investigator-rated hair growth and quality versus placebo. But the gains are modest and were measured by subjective assessments and questionnaires after the trial's objective hair-count endpoint was abandoned because of unusable data. For men wanting a non-prescription, low-risk add-on, it's defensible; for serious male-pattern baldness, FDA-approved finasteride and minoxidil have far stronger evidence at a fraction of the cost.
We may earn a commission if you buy through this link, at no extra cost to you. It never affects our score. How we make money
Nutrafol Men is an oral dietary supplement marketed for "thinning hair" in men. It is made by Nutraceutical Wellness Inc. (which trades as Nutrafol), a company majority-owned by consumer-goods giant Unilever since 2022. Because it is sold as a supplement and not a drug, it is not FDA-approved — the U.S. Food and Drug Administration does not evaluate supplements for effectiveness before sale, and the standard "these statements have not been evaluated by the FDA" disclaimer applies (FDA, Dietary Supplement Health and Education Act).
The product is a proprietary blend Nutrafol calls the "Synergen Complex," delivering roughly 1,800–2,200 mg of active botanicals plus a separate vitamin/mineral base per four-capsule daily serving. It is positioned as a "whole-body" or "wellness" approach to hair thinning — targeting stress, inflammation, and DHT rather than only the hormonal pathway that prescription drugs address. It is sold direct-to-consumer by subscription and through many dermatology offices, which is part of why it is frequently described as "dermatologist-recommended" (a marketing phrase, not a regulatory endorsement).
Most male hair loss is androgenetic alopecia (male-pattern baldness), driven largely by dihydrotestosterone (DHT), a potent androgen that miniaturizes scalp hair follicles over time (NIH/MedlinePlus). Nutrafol's stated mechanism is multi-pathway: partially blunt DHT (via saw palmetto), reduce the stress hormone cortisol (via ashwagandha), lower inflammation and oxidative stress in the scalp (via curcumin and tocotrienols), and supply building blocks for the hair shaft (via collagen, biotin, and minerals).
This "multifactorial" framing is the core marketing differentiator and is biologically plausible — stress, inflammation, and nutritional gaps genuinely can contribute to shedding. The important caveat is that plausibility is not the same as proven, clinically meaningful regrowth. Each pathway has a different and uneven amount of evidence behind it, examined below.
Nutrafol does not publish exact milligram amounts for every botanical in the proprietary blend, which makes it hard to compare doses against the doses used in published studies — a recurring transparency limitation with proprietary formulas.
The most relevant ingredient for pattern hair loss. Saw palmetto inhibits 5-alpha-reductase, the enzyme that converts testosterone to DHT — the same enzyme family that prescription finasteride blocks. Small trials suggest oral saw palmetto can modestly reduce shedding and slightly increase density over 16 weeks (PMID 38021422), and a systematic review of saw palmetto in alopecia reported improvements in hair quality, density, and disease stabilization in many subjects but flagged generally low study quality and small trials (Evron et al., *Skin Appendage Disorders*, 2020). Crucially, its DHT suppression is much weaker than finasteride's: finasteride 1 mg lowers serum DHT by roughly 60–70%, whereas saw palmetto's effect is smaller and less consistent. So saw palmetto is the right *idea*, at a lower *intensity*.
Included as an adaptogen to lower stress and cortisol. Ashwagandha has reasonably good evidence for reducing perceived stress and improving sleep at studied doses (commonly 250–600 mg/day of standardized extract), per several randomized trials. Direct evidence that oral ashwagandha regrows hair is thin — the strongest recent hair-specific data come from a *topical* ashwagandha serum study, not the oral route used here. Its role in Nutrafol is best understood as treating a possible *contributing* factor (stress shedding/telogen effluvium), not pattern baldness itself.
An anti-inflammatory and antioxidant compound. There is laboratory and limited human evidence that curcumin can inhibit 5-alpha-reductase and reduce scalp inflammation, but no robust trial showing oral curcumin alone regrows hair in men. Reasonable as a supporting anti-inflammatory ingredient; not a proven hair-growth agent on its own.
A small 8-month study found tocotrienol supplementation increased hair count by about 34.5% versus a slight decline in placebo in volunteers with hair loss (Beoy et al., Tropical Life Sciences Research, 2010; PMID 24575202). It is a single small study, but it is one of the few ingredient-specific trials showing a hair-count benefit, attributed to reduced scalp oxidative stress.
Marine collagen provides amino acids used in keratin and has in-vitro signals for supporting dermal papilla cells, but human regrowth evidence is weak. Biotin only helps hair in people who are genuinely biotin-deficient — which is rare — and biotin can interfere with lab tests (FDA safety communication, 2017), including some thyroid and troponin assays. Zinc and selenium matter when low, but excess selenium can paradoxically *cause* hair loss.
Bottom line on ingredients: the formula is rationally designed and several components have *some* supportive data, but most evidence is for surrogate effects (DHT, stress, oxidative stress) rather than large, replicated regrowth, and proprietary dosing prevents verifying that each ingredient is present at a studied dose.
The headline evidence is a 6-month, multicenter, randomized, double-blind, placebo-controlled trial published in the *Journal of Cosmetic Dermatology* in 2025 (Bhatia et al.; doi:10.1111/jocd.16778; PMC11701407). What it found, and its limitations, both matter.
What it showed: among men who completed the study (52 active, 33 placebo), blinded investigators rated hair growth as improved in 79% of the Nutrafol group versus 51% of placebo (p<0.01), and hair quality improved in 74% versus 54% (p=0.026). On a self-report questionnaire, 85% of active users versus 55% of placebo felt the product was effective at slowing thinning (p<0.05).
The serious limitation: the trial's pre-specified primary endpoint — actual terminal hair counts measured by an imaging device — was unusable because of protocol deviations at one site. That means the most objective measure (counting hairs) was lost, and the positive results that remain are largely investigator impressions and patient self-report, which are more susceptible to bias. The study was also funded by Nutrafol, and several authors are company employees, advisors, or grant recipients.
Put plainly: this is real, peer-reviewed, placebo-controlled evidence — better than most supplements have — but it is maker-funded, modest in size (about 85 completers), reliant on subjective endpoints after the objective one failed, and shows improvement in *ratings* rather than a hard, independently verified hair-count gain. There is no large independent trial confirming it.
Reasonable candidates: men with early, mild thinning who want a low-commitment first step; men who cannot tolerate or refuse finasteride (e.g., due to sexual side-effect concerns) and want a gentler DHT-leaning option; and men whose shedding may be partly stress- or nutrition-related. Reassuringly, the trial found no signal that Nutrafol worsened sexual function (no adverse trend on the Arizona Sexual Experience Scale), which is a common worry with finasteride.
Who should skip it: men who want the best evidence-based regrowth (finasteride and/or minoxidil are far better supported); anyone wanting guaranteed dosing transparency; people who are pregnant or could become pregnant should not handle the women's version, and saw-palmetto-containing products are generally avoided in those contexts. Men with advanced baldness (large bald areas with no fine hairs) are unlikely to benefit from any non-surgical option. Anyone on blood thinners or with shellfish allergy (marine collagen) or who is having lab work (biotin interference) should consult a clinician first.
In the published trial, the only reported issues were mild gastrointestinal complaints (8 events across 6 subjects, split evenly between active and placebo), no serious adverse events, and no sexual-function decline. Overall, Nutrafol Men has a benign short-term safety profile.
The broader caveats are inherent to supplements: long-term safety data are limited, the FDA does not verify supplement contents pre-market, and quality depends on the manufacturer. Saw palmetto can rarely cause GI upset or mild bleeding-related effects; biotin can skew lab tests; and as a "blend," the precise amount of each compound is not fully disclosed. None of these are alarming, but they are reasons to tell your doctor you're taking it.
The dose is four capsules once daily, taken with a meal (food improves absorption of the fat-soluble botanicals and reduces stomach upset). Like all hair treatments, it works on the hair cycle, so expect to commit at least 3–6 months before judging results, and benefits stop when you stop. There is no loading dose or titration.
Pricing (U.S., as of 2025) is roughly $88 for a one-time bottle, dropping to about $79/month on subscription, with multi-month plans (around $224 for 3 months) lowering the per-month cost. Subscriptions bundle extras like a hair-mineral test, wellness coaching, and a Headspace meditation membership. That works out to roughly $950–$1,050 per year.
For context: generic finasteride 1 mg and topical minoxidil 5% — the two FDA-approved options with the strongest evidence — together typically cost a small fraction of that (often under $200–$300/year via telehealth or generics). So Nutrafol is a premium-priced product whose evidence is weaker and more conflicted than the cheaper, better-proven prescription/OTC standards.
Versus finasteride (oral, FDA-approved): Finasteride has the strongest evidence in male-pattern hair loss — the pivotal placebo-controlled trials showed increased hair counts versus placebo, and a long-term analysis of those Phase III studies (1,553 men over 5 years) found finasteride 1 mg markedly reduced the likelihood of developing further visible loss (PMID 18573712). Its trade-off is potential sexual side effects in a minority of men. Nutrafol is gentler but markedly less effective and less rigorously proven.
Versus minoxidil (topical/oral): Minoxidil is FDA-approved (topical) and works by a different, growth-stimulating mechanism. It has robust evidence and is cheap. It requires daily application (topical) or off-label prescribing (oral). Minoxidil and finasteride are complementary and are the evidence-based backbone of treatment; Nutrafol is an add-on at best.
Versus other supplements (Viviscal, biotin pills, generic saw palmetto): Nutrafol's edge over rival supplements is that it actually has a published placebo-controlled trial, which most competitors lack. Among supplements, that makes it one of the better-studied — but the bar in this category is low, and the trial's flaws keep it well short of drug-grade proof.
Nutrafol Men is a thoughtfully formulated, generally safe, premium supplement with more clinical backing than almost any competitor — but that backing is maker-funded, modest, leans on subjective endpoints after its objective hair-count measure failed, and shows improvement in *perception and quality ratings* rather than a hard, independently confirmed regrowth number. It is a defensible choice for men with early, mild, or stress-related thinning who want a low-side-effect option or who decline prescription drugs. But anyone whose top priority is the most effective, best-proven, and most cost-efficient approach should start with FDA-approved finasteride and/or minoxidil — ideally under a clinician's guidance — and consider Nutrafol as a complement, not a replacement. Set expectations for "less shedding and somewhat better-looking hair," not dramatic regrowth, and re-evaluate after 6 months.
Nutrafol Men is an oral nutraceutical (not a drug) that aims to address several contributors to thinning hair at once rather than acting on a single pathway. Standardized saw palmetto is included to mildly reduce conversion of testosterone to DHT, the hormone that shrinks genetically sensitive follicles; ashwagandha is an adaptogen meant to blunt stress hormones like cortisol; and curcumin, tocotrienols (vitamin E) and other antioxidants target oxidative stress and micro-inflammation around the follicle. Vitamins, minerals, hydrolyzed marine collagen (fish-derived) and amino acids supply building blocks for the hair shaft. The idea is to nudge follicles back toward the active growth (anagen) phase. Note that its DHT-lowering effect from saw palmetto is far weaker and less established than prescription finasteride, and the multi-ingredient design makes it hard to know which components, if any, drive results.
Active ingredient: Saw palmetto, Ashwagandha, Marine collagen
The pivotal evidence is a 6-month, multi-center, randomized, double-blind, placebo-controlled trial in men with thinning hair, published in the Journal of Cosmetic Dermatology (Bhatia et al., 2025; PMC11701407). Of 112 enrolled, 85 completed per protocol (52 active, 33 placebo). Notably, the original objective primary endpoint—change in mean terminal hair count via Canfield HairMetrix—was abandoned because numerous protocol deviations at clinical sites rendered many measurements unusable, so only secondary outcomes are reported. At Day 180, blinded investigators rated hair growth "improved" in 79% of the active group versus 51% on placebo (p<0.01) and hair quality improved in 74% versus 54% (p=0.026). On a self-report questionnaire, 85% versus 55% felt the treatment slowed their hair loss (p<0.05) and 46% versus 24% were satisfied with hair on top (p<0.05). So the trial shows a real, statistically significant edge over placebo, but the surviving outcomes are subjective, the dropout (about 24%) was substantial, and the study was funded by Nutraceutical Wellness Inc. (Nutrafol's maker) with several authors employed by or paid as advisors to the company.
A realistic timeline of what Nutrafol Men users typically experience. Individual results vary; this is educational, not medical advice.
You start the daily routine: 4 capsules once a day with a meal. There is no titration or prescription; consistency at the same time each day is the main thing to lock in. No visible change is expected yet.
Most people notice nothing in the mirror; this is when the formula's vitamins, minerals and botanicals are building up in your system. Some men report a temporary uptick in shedding as resting follicles cycle out, which Nutrafol notes is normal but not guaranteed. The earliest sign a few users report is slightly less daily shedding around the 8-week mark.
This is the typical window for the first noticeable changes: reduced shedding and breakage, and sometimes new shorter regrowth hairs, often near the hairline. Results are not universal and many men still see little at this stage. Nutrafol's own messaging frames 3 months as the point to reassess, not to judge final results.
If the product is working for you, this is when improvements in fullness, thickness and scalp coverage tend to become most apparent. Nutrafol's company-sponsored 6-month study reported the majority of men saw improved hair quality and scalp coverage, but these are small, brand-funded trials and individual results vary widely.
Six months of consistent daily use is the standard benchmark to honestly evaluate whether Nutrafol is helping you. If you have seen no change by now, it may not be effective for your type of hair loss and a clinician or dermatologist visit is worth considering.
Men who respond and keep taking it daily often report their best results continuing past 6 months. Gains are not permanent: like most hair treatments, benefits typically fade over several months if you stop, so maintaining results means staying on the daily routine.
Nutrafol Men is generally well tolerated. In the trial, eight possibly or probably related adverse events occurred in six subjects (three in the active group, three on placebo), all gastrointestinal—bloating, stomach irritation, diarrhea, intermittent nausea—with two participants withdrawing for moderate GI upset and no serious adverse events. Outside the trial, users occasionally report mild stomach upset, headache, or unwanted body or facial hair from general follicle stimulation. A key practical caution: the formula's biotin can interfere with lab tests (thyroid, troponin/cardiac, hormone panels), and the FDA has linked biotin interference to falsely low troponin results, including one reported death, so stop biotin-containing supplements before bloodwork (commonly advised at least 72 hours ahead) and tell your provider you take it. Botanical supplements such as saw palmetto and ashwagandha have rare case reports of liver issues; stop and see a doctor if you develop dark urine, jaundice, or upper-right abdominal pain. Dietary supplements are not reviewed by the FDA for safety and efficacy the way prescription drugs are.
Starts at $88/mo from Nutrafol.
As of 2026, Nutrafol Men typically runs about $88 for a one-time single bottle (one-month supply) and around $79/month on a standard monthly subscription (roughly a 10% saving), with larger discounts—commonly 15-25%—on prepaid 3-month or 6-month plans (a 3-month subscription is around $237, sometimes lower with deeper promotions). It is a dietary supplement, so it is not covered by health insurance and does not qualify for typical pharmacy discount cards; however, many FSA/HSA accounts may reimburse it, and it's sometimes sold through dermatology and med-spa offices. For comparison, generic finasteride and minoxidil—both FDA-approved with stronger regrowth evidence—often cost roughly $10-$30/month (frequently under $30 with pharmacy coupons), making Nutrafol a premium-priced choice. Prices vary by retailer and promotion, so confirm the current price at checkout.
Prices current as of May 29, 2026 and exclude promo codes; cash-pay and channel pricing change frequently — confirm with the pharmacy or provider.
If you have early thinning, prefer a drug-free route, and can commit to roughly $79-$88/month for at least six months, Nutrafol Men is a legitimate, generally well-tolerated choice backed by an actual placebo-controlled trial. Just know the proven benefit is incremental, the strongest data is investigator- and self-reported, and the study was funded by the manufacturer with several authors employed by or paid as advisors to the company. Talk to a clinician, and consider proven prescription options if regrowth is your real goal.
In its 6-month randomized, placebo-controlled trial, blinded investigators rated hair growth as improved in 79% of Nutrafol Men users versus 51% on placebo, a statistically significant difference (p<0.01). So it shows a real but modest benefit over placebo—though the surviving outcomes were judged subjectively after the objective hair-count endpoint was dropped, the study was manufacturer-funded, and it is weaker than FDA-approved finasteride or minoxidil.
Plan on 3 to 6 months of daily use before judging results, with some men noticing reduced shedding around 2-3 months. The clinical trial measured outcomes at 6 months, so consistency over that full window is important, and benefits typically fade if you stop taking it.
As of 2026, expect about $88 for a one-time bottle (one-month supply) or around $79/month on subscription, with larger discounts on prepaid 3- or 6-month plans (a 3-month subscription is roughly $237). It's a dietary supplement, so insurance doesn't cover it, though FSA/HSA funds may apply. By comparison, generic finasteride and minoxidil often cost under $30/month.
The most common side effects are mild and gastrointestinal—bloating, stomach upset, occasional nausea or diarrhea. The clinical trial reported no serious adverse events. Rarely, users note unwanted body or facial hair. The formula's biotin can interfere with lab tests (including cardiac troponin), so tell your provider you take it and stop before bloodwork.
No—finasteride and minoxidil are FDA-approved with much stronger, longer-standing evidence for regrowing male-pattern hair, and they cost far less. Nutrafol's saw palmetto blocks DHT far more weakly than finasteride. Nutrafol Men is best viewed as a drug-free option or an add-on, not a replacement for proven medications. Discuss the right approach with a clinician.
Generally yes—they work through different mechanisms and are often combined, but there's no formal interaction guideline, so check with your doctor first. This is especially important if you have liver disease, a hormone-sensitive condition, or take other medications. A clinician can confirm it's appropriate for you.
It's not specifically known for triggering the initial shedding sometimes seen when starting minoxidil. In the trial, no participants in either group recorded a positive hair-pull (active-shedding) test. Any temporary shedding should be discussed with a clinician if it's significant or persistent.
Largely, yes, if you want to maintain results. Like most hair treatments, its effect depends on continued use, and benefits typically fade after you stop because it doesn't permanently change the hair-growth cycle. There's no published data showing results persist long-term after discontinuation.
Yes. It contains biotin, which can skew thyroid, cardiac (troponin), and hormone lab results; the FDA has warned that biotin interference can cause falsely low troponin readings. Stop biotin-containing supplements before bloodwork (often advised at least 72 hours ahead) and tell your provider you use it.
Affiliate link — we may earn a commission at no extra cost to you, and it never changes our rankings or score. Disclosure
Same-category options, scored on the same six-axis rubric. Higher is better.
| H | Hims Hair (Finasteride + Minoxidil)Prescription | 8.3/10 | Read → |
| H | Happy Head Prescription TopicalOver-the-counter | 8.2/10 | Read → |
| K | KeepsPrescription | 8.0/10 | Read → |
| M | Musely Hair Formula RxOver-the-counter | 8.0/10 | Read → |
| V | Vegamour GRO Hair SerumOver-the-counter | 7.8/10 | Read → |
| N | Nutrafol Menthis reviewOver-the-counter | 7.0/10 | — |